Whalegun
Home

David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 01/15

Trade details

Type
Insider sale
Amount
$370,677.87
Shares · price
11,367 sh · $32.61 a share
Held after
50,437 sh
Stock
Mineralys Therapeutics MLYS
Person
David Malcom RodmanChief Medical Officer
Trade date
26/01/14
Filed
26/01/15
Days to filing
1 days

Sold 18.4% of holdings

Share of holding sold
18.4%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/15~02/13

David Malcom Rodman's recent trades

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $11.7K

    Filed 09/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $216.9K

    Filed 09/14

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $67K

    Filed 09/09

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $10.6K

    Filed 08/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $372.2K

    Filed 08/13